Nosocomial COVID-19 Infections in Patients Hospitalized at the Metz-Thionville Regional Hospital in 2021

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

216 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-01-03

Study Completion Date

2022-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The rate of nosocomial SARS-CoV2 infections found in the different studies since the beginning of the pandemic is very variable (\<1% in hospitals in the USA to about 20% in a British hospital). Mortality related to these nosocomial SARS-CoV2 infections is higher than in the general population. The risk factors identified for this nosocomial acquisition are multiple. We were confronted with nosocomial acquisitions and cluster situations in the services, without exhaustive data to measure these phenomena, and we lacked data to consider areas for improvement.

The objectives of this study are to determine the proportion of nosocomial SARS COV 2 infections in the total number of patients hospitalized with a Covid-19 infection at the CHR Metz-Thionville in 2021, and to describe the characteristics of this population.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

COVID-19 - Multicenter Study on Nosocomial Transmission of SARS-CoV-2 Virus

NCT04290780

Infection Viral

COMPLETED

NOsocomial Dissemination Risk of SARS-Cov2

NCT04339881

Sars-CoV2

COMPLETED

Nosocomial Respiratory Virus Infection

NCT06643039

Nosocomial Infections

RECRUITING NA

Registry of Management Strategies for Patients With COVID-19 in Healthcare Establishments

NCT05069389

COVID-19 Infection

ACTIVE_NOT_RECRUITING

Prevent and Control COVID-19 Infection in Nursing Homes on the Risk of Death of Residents

NCT04740658

Covid19

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

SARS CoV 2 Infection

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

SARS-CoV 2 infected patients hospitalized at CHR Metz-Thionville in 2021 during the first period

SARS-CoV 2 infected patients hospitalized at CHR Metz-Thionville in April 2021

Nosocomial SARS-COV 2 Infection proportion

Intervention Type OTHER

Proportion of Nosocomial SARS-COV 2 Infections in Patients Hospitalized at the Metz-Thionville Regional Hospital in 2021

SARS-CoV 2 infected patients hospitalized at CHR Metz-Thionville in 2021 during the second period

SARS-CoV 2 infected patients hospitalized at CHR Metz-Thionville from June to September 2021

Nosocomial SARS-COV 2 Infection proportion

Intervention Type OTHER

Proportion of Nosocomial SARS-COV 2 Infections in Patients Hospitalized at the Metz-Thionville Regional Hospital in 2021

SARS-CoV 2 infected patients hospitalized at CHR Metz-Thionville in 2021 during the third period

SARS-CoV 2 infected patients hospitalized at CHR Metz-Thionville in December 2021

Nosocomial SARS-COV 2 Infection proportion

Intervention Type OTHER

Proportion of Nosocomial SARS-COV 2 Infections in Patients Hospitalized at the Metz-Thionville Regional Hospital in 2021

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Nosocomial SARS-COV 2 Infection proportion

Proportion of Nosocomial SARS-COV 2 Infections in Patients Hospitalized at the Metz-Thionville Regional Hospital in 2021

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients hospitalised at the CHR Metz-Thionville in medicine, surgery and obstetrics (MCO) or geriatric follow-up and rehabilitation care (SSR) units, in 2021 for a Covid-19 infection defined by the existence of a positive PCR result for SARS-CoV2 during the stay, or by the existence of an ICD10 code for COVID in the PMSI data of the health care establishment